Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital DOI: 10.1200/CCI.21.00177 Digital Cancer Research
From bench to byte: A UK perspective on data-driven cancer research DOI: 10.1016/j.ejca.2026.116751 Digital Cancer Research
Translating the machine; An assessment of clinician understanding of ophthalmological artificial intelligence outputs DOI: 10.1016/j.ijmedinf.2025.105958 Digital Cancer Research
Patient attrition in Molecular Tumour Boards: a systematic review DOI: 10.1038/s41416-022-01922-3 Digital Cancer Research
Digital ECMT Cancer Trial Matching Tool: an Open Source Research Application to Support Oncologists in the Identification of Precision Medicine Clinical Trials DOI: 10.1200/CCI.22.00137 Digital Cancer Research
Overall survival for bevacizumab therapy in metastatic colorectal cancer: an updated analysis of the TRAVASTIN study DOI: 10.1016/j.clcc.2025.11.001 Digital Cancer Research
UpSMART: five years of digital innovation in cancer clinical research—achievements, challenges, and recommendations DOI: 10.3389/fdgth.2025.1708067 Digital Cancer Research
SylloBio-NLI: Evaluating Large Language Models on Biomedical Syllogistic Reasoning DOI: 10.18653/v1/2025.naacl-long.371 Digital Cancer Research
cfDNA methylome profiling for detection and subtyping of small cell lung cancers DOI: 10.1038/s43018-022-00415-9 Bioinformatics & Biostatistics Nucleic Acids Biomarkers Preclinical Pharmacology
A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary DOI: 10.1038/s41467-024-47195-7 Bioinformatics & Biostatistics Nucleic Acids Biomarkers
